For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...

Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes ...

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish ...

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is ...

In Senator Bernie Sanders's letter to chief executive Lars Fruergaard Jørgensen, he says drugmaker Novo Nordisk charges $969 ...

The high price of some popular weight loss drugs is at the center of a congressional committee on Tuesday with a ...

U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...